FDA Panel Rejects Gout Drug on Safety Concerns

Safety concerns led an FDA advisory panel to oppose approval of a new drug for gout, despite widespread enthusiasm for the medication’s effectiveness against the painful disorder.

Read the original here:

FDA Panel Rejects Gout Drug on Safety Concerns

Posted by on June 22, 2011. Filed under Health, News. You can follow any responses to this entry through the RSS 2.0. You can skip to the end and leave a response. Pinging is currently not allowed.